Today

Agents

Chat

Arena

Discover

More

App

Beam Therapeutics: Wedbush raises target price to $30 from $28

BEAM•2026-11-04

Wedbush raised its target price for Beam Therapeutics to $30 from $28.

Related News

M

Madison Square Garden Entertainment outlines live entertainment growth opportunities

MSGE•2026-11-04

Ideaya Biosciences: Wedbush raises target price to $63 from $60

IDYA•2026-11-04

Wedbush raises Denali Therapeutics target price to $24 from $23

DNLI•2026-11-04

Pediatrix Medical Group hosts NEO conference for neonatology

MD•2026-11-04

TAL Education Group announces dividend of R$ 0.0508947540 per unit

TAL•2026-11-04

Beam Therapeutics: Wedbush raises target price to $30 from $28 - BEAM News | Rallies